Global Malaria Diagnostics Market Size, Share, Opportunities, And Trends By Technique (Rapid Diagnostic Tests, Microscopy, Nucleic Acid Detection), By End-Users (Hospitals and Clinics, Diagnostic Centers), And By Geography - Forecasts From 2025 To 2030

Malaria Diagnostics Market Size:

The Global Malaria Diagnostics Market is expected to grow from USD 710.504 million in 2025 to USD 908.749 million in 2030, at a CAGR of 5.05%.

Malaria Diagnostics Market Trends:

High-quality malaria diagnostic kits are important, as any misdiagnosis or delay in treatment can result in significant morbidity and mortality. Malaria diagnostics provide early and accurate diagnosis of the disease, which is essential for rapid and effective disease management.

As per a report by the WHO, in 2016, there were an estimated 216 million cases of malaria, an increase of about 5 million cases over 2015. Molecular diagnostics and rapid diagnostic tests (RDTs) are examples of malaria diagnostic techniques that are frequently used. The growth in the market may be attributed to the advancements in technology for the rapid detection of the disease. A rise in government funding regarding malaria diagnostic research and awareness in developing regions will also boost the market during the given time frame. However, low awareness among people regarding malaria diagnostics may restrain the growth of the market during the given forecast period.

This research study examines the current market trends related to demand, supply, and sales, in addition to recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market.

The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases, and journals, among others, have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments.

The values obtained are correlated with the primary inputs of the key stakeholders in the global malaria diagnostics market value chain. The last step involves complete market engineering, which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and more efficient understanding of the global malaria diagnostics market.

Major industry players profiled as part of the report are Motic (Xiamen) Electric Group Co., Ltd., Sight Diagnostics Ltd., bioMérieux SA, Intellectual Ventures Laboratory, LLC, Access Bio, Inc., Sysmex Europe GmbH, Abbott Laboratories, Meridian Bioscience, Inc., QuantuMDx Group Ltd., Hemex Health, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., ThermFisher Scientific Inc., and Premier Medical Corporation Pvt. Ltd.   

Malaria Diagnostics Market Segmentation:

• By Technology
  • Rapid Diagnostic Tests (RDTs)
  • Microscopy
  • Molecular Diagnostics
  • Serology-based Tests
  • Other Technologies
• By End-Users
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • NGOs and Government Health Programs
• By Distribution Channel
  • Direct Tenders & Institutional Sales
  • Retail and Private
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MALARIA DIAGNOSTICS MARKET BY TECHNOLOGY

5.1. Introduction

5.2. Rapid Diagnostic Tests (RDTs)

5.3. Microscopy

5.4. Molecular Diagnostics

5.5. Serology-based Tests

5.6. Other Technologies

6. MALARIA DIAGNOSTICS MARKET BY END-USERS

6.1. Introduction

6.2. Hospitals and Clinics

6.3. Diagnostic Laboratories

6.4. Research Institutes

6.5. NGOs and Government Health Programs

7. MALARIA DIAGNOSTICS MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction

7.2. Direct Tenders & Institutional Sales

7.3. Retail and Private

8. MALARIA DIAGNOSTICS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Technology

8.2.2. By End-Users

8.2.3. By Distribution Channel

8.2.4. By Country

8.2.4.1. USA

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Technology

8.3.2. By End-Users

8.3.3. By Distribution Channel

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Technology

8.4.2. By End-Users

8.4.3. By Distribution Channel

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.2. Germany

8.4.4.3. France

8.4.4.4. Spain

8.4.4.5. Others

8.5. Middle East and Africa

8.5.1. By Technology

8.5.2. By End-Users

8.5.3. By Distribution Channel

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.2. UAE

8.5.4.3. Others

8.6. Asia Pacific

8.6.1. By Technology

8.6.2. By End-Users

8.6.3. By Distribution Channel

8.6.4. By Country

8.6.4.1. China

8.6.4.2. Japan

8.6.4.3. South Korea

8.6.4.4. India

8.6.4.5. Indonesia

8.6.4.6. Thailand

8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Motic (Xiamen) Electric Group Co., Ltd.

10.2. Sight Diagnostics Ltd.

10.3. bioMérieux SA

10.4. Intellectual Ventures Laboratory, LLC

10.5. Access Bio. Inc.

10.6. Sysmex Europe GmbH

10.7. Abbott Laboratories

10.8. Meridian Bioscience, Inc.

10.9. QuantuMDx Group Ltd.

10.10. Hemex Health, Inc.

10.11. F. Hoffmann-La Roche Ltd.

10.12. Bio-Rad Laboratories, Inc.

10.13. Thermo Fisher Scientific Inc.

10.14. Premier Medical Corporation Pvt. Ltd.

11. APPENDIX

11.1. Currency

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key Benefits for the Stakeholders

11.5. Research Methodology

11.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES

Motic (Xiamen) Electric Group Co., Ltd.

Sight Diagnostics Ltd.

bioMérieux SA

Intellectual Ventures Laboratory, LLC

Access Bio. Inc.

Sysmex Europe GmbH

Abbott Laboratories

Meridian Bioscience, Inc.

QuantuMDx Group Ltd.

Hemex Health, Inc.

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Premier Medical Corporation Pvt. Ltd.